EPIX
ESSA Pharma
EPIX
EPIX
Delisted
EPIX was delisted on the 8th of October, 2025.
59 hedge funds and large institutions have $119M invested in ESSA Pharma in 2022 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 10 increasing their positions, 21 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
58% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 19
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
59
Holding in Top 10
–
Calls
$56K
Puts
–
Top Buyers
| 1 | +$11.8M | |
| 2 | +$5.37M | |
| 3 | +$1.13M | |
| 4 |
Millennium Management
New York
|
+$697K |
| 5 |
HF
HRT Financial
New York
|
+$299K |
Top Sellers
| 1 | -$4.5M | |
| 2 | -$3.15M | |
| 3 | -$2.79M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$2.32M |
| 5 |
BlackRock
New York
|
-$525K |